.png){kind=small}
WHAT IT IS
A synthetic analogue of growth hormone–releasing hormone (GHRH) that signals the pituitary gland to release growth hormone.
PHYSICIAN-DIRECTED SERMORELIN CARE IN FLORIDA
Sermorelin Therapy in Jupiter, Florida
A physician-led evaluation of a growth hormone–releasing hormone analogue—what it may do, what the evidence does not establish, and how laboratory monitoring guides decisions.
Timothy Mackey, D.O., Medical Director
Florida License OS9185 · Updated September 2026
A consultation does not guarantee a prescription. Eligible Florida patients may be seen by telemedicine when clinically appropriate.
Timothy Mackey, D.O.Medical Director · Physician-led evaluation and monitoring
PHYSICIANIndividual evaluation
FLORIDALicense OS9185
★★★★★4.9 Google rating
A+BBB rating
MONITORINGOngoing follow-up
Three things to know before deciding
REGULATORY STATUS
Sermorelin preparations used in current practice are not FDA-approved finished drug products. Compounded medications are evaluated case by case.
CLINICAL LENS
It is not a shortcut for anti-aging, muscle gain, or weight loss. History, symptoms, IGF-1, and risk factors matter.
CLINICAL CONTEXT
What is sermorelin—and where does it fit?
Sermorelin acts through the body’s growth-hormone signaling pathway rather than supplying growth hormone directly. Its effect depends on pituitary function and can increase insulin-like growth factor-1 (IGF-1).
That mechanism is clinically relevant, but it does not prove broad claims commonly made online about fat loss, recovery, sleep, or “reversing aging.” A responsible decision begins with an individualized medical evaluation.
Read the peptide therapy cornerstone guide →
Who may need evaluation—and what requires caution
An evaluation may include
- Symptoms, goals, sleep, recovery, and medical history
- Medication and supplement review
- IGF-1 and other laboratories when clinically appropriate
- Discussion of realistic expectations and alternatives
Important reasons for added caution
- Active or recent malignancy
- Pituitary disease or unexplained endocrine findings
- Pregnancy or breastfeeding
- Uncontrolled glucose abnormalities or significant untreated illness
A four-step physician-guided process
Consultation
Review symptoms, goals, medical history, medications, and prior treatment.
Evaluation
Complete a focused exam, records review, and labs when clinically appropriate.
Shared decision
Compare evidence, regulatory status, alternatives, uncertainty, cost, and risk.
Follow-up
If treatment is appropriate, monitor response, side effects, and ongoing need.
SAFETY & MONITORING
What responsible care should address
Sermorelin can affect a hormone pathway with effects throughout the body. Monitoring is more than a formality.
- Injection-site reactions, headache, flushing, dizziness, or nausea may occur.
- Fluid retention, joint discomfort, changes in glucose handling, or an excessive IGF-1 response require reassessment.
- Compounded products are not reviewed by FDA for safety, effectiveness, or manufacturing quality in the same way as an approved finished drug.
- Competitive athletes should verify current anti-doping rules before considering any growth-hormone–related substance.
Call 911 for a medical emergency. Contact the prescribing clinician promptly for concerning or persistent symptoms.
Put this option in the right clinical context
Tesamorelin
FDA-approved for one specific indication
Explore this page →Peptide therapy guide
Compare approved, compounded, and investigational categories
Explore this page →In-person and telemedicine care
NovaGenix serves patients at 609 N. Hepburn Ave., Suite 106, Jupiter, Florida, with telemedicine available to eligible patients throughout Florida.
Clear next steps after evaluation
Cost and availability depend on the medically appropriate option, pharmacy or product, monitoring, and insurance status. The team explains expected costs before treatment begins.
Clear answers, without overpromising
Is sermorelin FDA-approved?
Current sermorelin preparations used in practice are not FDA-approved finished drug products. If compounded, the preparation is made for an individual patient by a licensed pharmacy and is not equivalent to FDA approval.
Is sermorelin the same as growth hormone?
No. Sermorelin is a GHRH analogue that signals the pituitary gland; injectable growth hormone supplies growth hormone directly.
Will sermorelin cause weight loss or build muscle?
Those outcomes should not be promised. Any change varies by patient, and broad anti-aging, fat-loss, or muscle-building claims are not established indications.
What testing is considered?
The physician may review IGF-1, glucose-related markers, thyroid or other endocrine data, and additional labs based on history and symptoms.
Can Florida patients be seen by telehealth?
Eligible Florida patients may begin with telemedicine when clinically appropriate. Some evaluations or follow-up needs may require in-person care or local laboratory testing.
Start with a physician conversation
Discuss your goals, medical history, evidence-based options, and whether this therapy—or a different approach—may be appropriate.
